Pediatric GVHD Low Risk Steroid Taper Trial
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- John E Levine, MD, MS
Icahn School of Medicine at Mount Sinai
Principal Investigator - Muna Qayed, MD, MS
Children's Healthcare of Atlanta, Emory University School of Medicine
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the Hospital for Sick Children
Toronto, Ontario, Canada
- Children'S Hospital of Los Angeles
Los Angeles, California, United States
- Children'S National Hospital
Washington D.C., District of Columbia, United States
- Children'S Healthcare of Atlanta
Atlanta, Georgia, United States
- Boston Children'S Hospital Dana Farber Cancer Institute
Boston, Massachusetts, United States
- Icahn School of Medicine at Mount Sinai
New York, New York, United States
- Memorial Sloan Kettering Cancer Center
New York, New York, United States
- Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
- Vanderbilt University Medical Center
Nashville, Tennessee, United States
- Texas Children'S Hospital, Baylor College of Medicine
Houston, Texas, United States
- Medical College of Wisconsin / Children'S Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 20 Oct 2022
- Primary completion
- 27 Mar 2025
- Completion
- 25 Feb 2026
- Last update posted
- 3 Jun 2026
- Registered enrollment
- 50
- Registry id
- NCT05090384
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.